Research
Adherence
Individuals with Type 2 Diabetes should be screened for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the FIB-4 index, as nearly 70% of T2D patients are affected.
If you have diabetes, ask your doctor to check your liver health using a simple calculation called FIB-4. This test uses your age and blood results to estimate liver scarring risk. Since 70% of people with diabetes have some degree of liver fat, this check is essential for your overall health.
GoodSupportsHIGH confidence
Individuals with T2D or prediabetes, especially those with overweight or obesity, or other cardiometabolic risk factors or established CVD, must be screened for MASLD using appropriate assessment tools... MASLD... is highly prevalent in T2D, affecting nearly 70% of individuals with T2D.
Why this rating
Consensus guideline based on high prevalence data.
Source
Emirates Diabetes and Endocrine Society Consensus for the Management of Type 2 Diabetes Mellitus (2026 Update)
Fatheya Alawadi et al. · Dubai Diabetes and Endocrinology Journal · 2026
clinical_guideline
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →